VIRI and the journey of targeted medicine
Keywords:
Virus-like particles, VLPs, nanocarriers, targeted delivery, anticancer therapyAbstract
This science communication story presents Athena, a science student who designs VIRI, a virus-like particle (VLP) that transports drugs to tumor cells. The story explains that VLPs resemble viruses on the outside because they retain a protein capsid, but they are empty on the inside and lack the genetic material required for replication, so they cannot cause disease. Instead, they function as vehicles that protect the medicine, recognize the correct cell, and release it at its destination. Thus, they show that a therapy requires protection, direction, and precision.
References
Mejía-Méndez, J. L., Vázquez-Duhalt, R., Hernández, L. R., Sánchez-Arreola, E., & Bach, H. (2022). Virus-like particles: Fundamentals and biomedical applications. International Journal of Molecular Sciences, 23(15), 8579. doi: 10.3390/ijms23158579
He, J., Yu, L., Lin, X., Liu, X., Zhang, Y., Yang, F., & Deng, W. (2022). Virus-like particles as nanocarriers for intracellular delivery of biomolecules and compounds. Viruses, 14(9), 1905. doi: 10.3390/v14091905
Ikwuagwu, B., & Tullman-Ercek, D. (2022). Virus-like particles for drug delivery: A review of methods and applications. Current Opinion in Biotechnology, 78, 102785. doi: 10.1016/j.copbio.2022.102785
Travassos, R., Martins, S. A., Fernandes, A., Correia, J. D. G., & Melo, R. (2024). Tailored viral-like particles as drivers of medical breakthroughs. International Journal of Molecular Sciences, 25(12), 6699. doi: 10.3390/ijms25126699
Kim, K. R., Lee, A. S., Kim, S. M., Heo, H. R., & Kim, C. S. (2023). Virus-like nanoparticles as a theranostic platform for cancer. Frontiers in Bioengineering and Biotechnology, 10, 1106767. doi: 10.3389/fbioe.2022.1106767
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Revista de divulgación científica iBIO
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Self-archiving or deposit of the works in their post-publication version (editorial version) is permitted in any personal, institutional or thematic repository, social or scientific networks. The above applies from the moment of publication of the article in question on the website of the Revista de divulgación científica iBIO.
